Progen Scientists Profile Mechanism of PI-88 as Novel Antithrombotic at IBC's 11th Annual International Symposium - Advances in Anticoagulant, Antithrombotic and Thrombolytic Drugs.
Business Wire › October 04, 2000
Linked as:
Extract
Progen Scientists Profile Mechanism of PI-88 as Novel Antithrombotic at IBC's 11th Annual International Symposium - Advances in Anticoagulant, Antithrombotic and Thrombolytic Drugs.
Business Editors/Health & Medical Writers
BRISBANE, Australia--(BW HealthWire)--Oct. 4, 2000 Research conducted by Australian biotechnology company, Progen Industries, in collaboration with Loyola University Medical Center in Chicago, reveals Progen's anti-c...See the full content of this document
Sponsored links
